<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Singh AK</submitter><funding>DU-DST Pursue Grant</funding><funding>Council of Scientific and Industrial Research</funding><pagination>499-502</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5671431</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>57(4)</volume><pubmed_abstract>Four (1, 2, 4 and 6) synthetic quaternary ammonium derivatives of pyranochromenones and (coumarinyloxy)acetamides were synthesized and investigated for their antimicrobial efficacy on MRSA (Methicillin-resistant Staphylococcus aureus), and multi-drug resistant Pseudomonas aeruginosa, Salmonella enteritidis and Mycobacterium tuberculosis H37Rv strain. One of the four compounds screened i.e. N,N,N-triethyl-10-((4,8,8-trimethyl-2-oxo-2,6,7,8-tetrahydropyrano[3,2-g]chromen-10-yl)oxy)decan-1-aminium bromide (1), demonstrated significant activity against S. aureus, P. aeruginosa and M. tuberculosis with MIC value of 16, 35, and 15.62 µg/ml respectively. The cytotoxicity evaluation of compound 1 on A549 cell lines showed it to be a safe antimicrobial molecule, TEM study suggested that the compoun</pubmed_abstract><journal>Indian journal of microbiology</journal><pubmed_title>Antimicrobial Efficacy of Synthetic Pyranochromenones and (Coumarinyloxy)acetamides.</pubmed_title><pmcid>PMC5671431</pmcid><funding_grant_id>BSC 0302</funding_grant_id><pubmed_authors>Singh AK</pubmed_authors><pubmed_authors>Sharma SK</pubmed_authors><pubmed_authors>Prasad S</pubmed_authors><pubmed_authors>Kamble SS</pubmed_authors><pubmed_authors>Kumar B</pubmed_authors><pubmed_authors>Gautam HK</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors><pubmed_authors>Anand A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antimicrobial Efficacy of Synthetic Pyranochromenones and (Coumarinyloxy)acetamides.</name><description>Four (1, 2, 4 and 6) synthetic quaternary ammonium derivatives of pyranochromenones and (coumarinyloxy)acetamides were synthesized and investigated for their antimicrobial efficacy on MRSA (Methicillin-resistant Staphylococcus aureus), and multi-drug resistant Pseudomonas aeruginosa, Salmonella enteritidis and Mycobacterium tuberculosis H37Rv strain. One of the four compounds screened i.e. N,N,N-triethyl-10-((4,8,8-trimethyl-2-oxo-2,6,7,8-tetrahydropyrano[3,2-g]chromen-10-yl)oxy)decan-1-aminium bromide (1), demonstrated significant activity against S. aureus, P. aeruginosa and M. tuberculosis with MIC value of 16, 35, and 15.62 µg/ml respectively. The cytotoxicity evaluation of compound 1 on A549 cell lines showed it to be a safe antimicrobial molecule, TEM study suggested that the compoun</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2025-04-26T20:03:27.299Z</modification><creation>2019-03-27T00:09:07Z</creation></dates><accession>S-EPMC5671431</accession><cross_references><pubmed>29151652</pubmed><doi>10.1007/s12088-017-0675-z</doi></cross_references></HashMap>